IFINATAMAB DERUXTECAN BIOLOGICS LICENSE APPLICATION FOR CERTAIN PATIENTS WITH PREVIOUSLY TREATED EXTENSIVE-STAGE SMALL CELL LUNG CANCER VOLUNTARILY WITHDRAWN

Reuters · 1d ago

Please log in to view news